Synopsis of Social media discussions
The discussions reflect a balanced appreciation of the article, with mentions of how viral vectors deliver antigens and their role in vaccine strategies, indicating a moderate but meaningful engagement. The tone is technical but accessible, with phrases like 'convenient means' and 'strategy' highlighting interest and perceived importance.
Agreement
Moderate agreementMost discussions acknowledge the value of viral vectors in vaccine development, reflecting general support.
Interest
Moderate level of interestParticipants show moderate curiosity about the topic, indicating a reasonable level of engagement but not deep passion.
Engagement
Moderate level of engagementComments include references to specific applications, such as HIV vaccine strategies, suggesting some detailed understanding.
Impact
Moderate level of impactThe emphasis on research methods and potential uses suggests these discussions see the article as moderately influential in the field.
Social Mentions
YouTube
3 Videos
2 Posts
Blogs
3 Articles
News
10 Articles
Metrics
Video Views
301,602
Total Likes
3,034
Extended Reach
304,125
Social Features
18
Timeline: Posts about article
Top Social Media Posts
The Truth-Seekers Tavern
Replicating and non-replicating viral vectors for vaccine development
Published online 2007 Dec 11. doi: 10.1016/j.copbio.2007.10.010
"Viral vectors provide a convenient means to deliver vaccine antigens to select target cells or tissues."
https://t.co/dXUxsWVvtw
view full post
SophiaC
Replicating and non-replicating viral vectors for vaccine development - ScienceDirect https://t.co/Rtgss7vT0b
view full post
Posts referencing the article
Inactivated Vaccine Candidate for COVID-19 Explained
Discover how the PiCoVacc inactivated vaccine candidate was developed in response to the urgent need for COVID-19 solutions. This video simplifies complex vaccine mechanisms and reviews systematic studies from global experts.
September 4, 2020
301,217 views
Comparing Pfizer and Sputnik Vaccines Against COVID-19 Variants
This video analyzes current mutations and compares two vaccine platforms: Pfizer's mRNA and Sputnik's vector-based vaccines. It reviews systematic studies and expert opinions, highlighting the urgency for effective vaccines as SARS-CoV-2 variants emerge.
December 26, 2020
381 views
Understanding Covid-19 Vaccines: Insights and Developments
In this video, you will discover the effective and straightforward explanations of vaccines. We discuss five biological platforms for vaccine creation and the promising PiCoVacc, an inactivated SARS-CoV-2 vaccine that shows potential for clinical trials and effective neutralization against the virus.
August 20, 2021
5 views
-
Replicating and non-replicating viral vectors for vaccine development Published online 2007 Dec 11. doi: 10.1016/j.copbio.2007.10.010 "Viral vectors provide a convenient means to deliver vaccine antigens to select target cells or tissues." https://t.co/dXUxsWVvtw
view full postApril 18, 2024
3
-
SophiaC
@SophiaC_el (Twitter)Replicating and non-replicating viral vectors for vaccine development - ScienceDirect https://t.co/Rtgss7vT0b
view full postMay 8, 2021
1
Abstract Synopsis
- Viral vectors are used to deliver vaccine antigens directly to specific cells or tissues, offering a flexible approach for vaccine development.
- The choice between replicating and nonreplicating vectors depends on factors like the infectious agent's biology, the goal of the vaccine (preventing infection or boosting immunity), and safety concerns.
- A common HIV vaccine strategy involves priming with a replicating vector to activate immune responses, followed by boosting with either a similar or nonreplicating vector, or protein subunits, to achieve strong protective immunity.]
The Truth-Seekers Tavern
@TavernTruth (Twitter)